Price
No data yet.
Social Signal Score
Analyst Ratings
23 analystsRevenue
$815.30M+188.42%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- J. Eric Evans
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 16,000
- Beta
- 1.88
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 1.14
Financials
Revenue
$815.30M+188.4%Net Income
$-21.10MEBITDA
$125.20M+156.4%Free Cash Flow
$79.00M+265.0%EPS (diluted)
$-0.16Shares Outstanding (diluted)
128.87M+168.4%Operating Expenses
$40.60MCash & Debt
$354.50MReturn of Capital
$0.00Revenue by Segment (annual)
$6.54BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.31B | $-77.90M | $-0.61 |
| 2024 | $3.11B | $-168.10M | $-1.33 |
| 2023 | $2.74B | $-11.90M | $-0.09 |
| 2022 | $2.54B | $-54.60M | $-0.59 |
| 2021 | $2.23B | $-70.90M | $-1.12 |
| 2020 | $1.86B | $-116.10M | $-3.19 |
| 2019 | $1.83B | $-74.80M | $-2.29 |
| 2018 | $1.77B | $-205.71M | $-4.28 |
| 2017 | $1.34B | $-52.98M | $-1.09 |
| 2016 | $1.15B | $9.45M | $0.20 |
| 2015 | $959.89M | $1.43M | $0.04 |
| 2014 | $403.29M | $-65.90M | $-1.37 |
| 2013 | $284.60M | $-9.06M | $-0.19 |
| 2012 | $260.21M | $1.92M | $0.04 |
Valuation
SGRYhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
160+220.00%Social Signal Score
Mentions (14)
- Newsglobenewswire.com·3d ago·Neutral
SGRY Stock Alert: Halper Sadeh LLC is Investigating Whether Surgery Partners, Inc. is Obtaining a Fair Price for its Shareholders Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
View source ↗ - Newsglobenewswire.com·3d ago·Positive
SGRY Shareholders: Amparo Law Firm PLLC Is Investigating Whether Surgery Partners's $23.50-Per-Share Sale to HealthSpan Partners Delivers the Best Value for Shareholders Amparo Law Firm PLLC, through its Amparo Investor Rights practice, is investigating whether $23.50 per share is the best price Surgery Partners, Inc.
View source ↗ - Newsglobenewswire.com·11d ago·Neutral
SGRY Securities Notice: Surgery Partners Shareholders are Notified to Contact BFA Law about its Investigation into the $23.50 per Share Take-Private Merger NEW YORK, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: SGRY) is being taken private by Bon Secours Mercy Health, Inc. Surgery Partners is incorporated in Delaware. If you are a current stockholder of…
View source ↗ - Newszacks.com·13d ago·Positive
Surgery Partners (SGRY) Beats Q3 Earnings Estimates Surgery Partners (SGRY) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.13 per share a year ago.
View source ↗ - Newsglobenewswire.com·13d ago·Neutral
SGRY Deal Alert: Surgery Partners $23.50 per Share Merger Under Investigation – Contact BFA Law about the Pending Merger Investigation NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: SGRY) is being taken private by Bon Secours Mercy Health, Inc. Surgery Partners is incorporated in Delaware. If you are a current stockholder of Surgery Partners, In…
View source ↗ - Newsglobenewswire.com·16d ago·Neutral
SGRY Investigation Reminder: Surgery Partners Shareholders Notified of Investigation into $23.50 per Share Merger – Contact BFA Law NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: SGRY) is being taken private by Bon Secours Mercy Health, Inc. Surgery Partners is incorporated in Delaware. If you are a current stockholder of Surgery Partners, Inc.,…
View source ↗ - Newsglobenewswire.com·18d ago·Neutral
SGRY Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Surgery Partners to HealthSpan Partners MONSEY, N.Y., Nov. 04, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Surgery Partners, Inc. (NASDAQ: SGRY) (“SGRY”) to HealthSpan Partners for $23.50 per share in cash.
View source ↗ - Newsglobenewswire.com·18d ago·Neutral
SGRY Investigation Reminder: Surgery Partners $23.50 per Share Merger Triggers Investigation on Behalf of Shareholders – Contact BFA Law if You Hold Shares NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: SGRY) is being taken private by Bon Secours Mercy Health, Inc. Surgery Partners is incorporated in Delaware. If you are a current stockholder of…
View source ↗ - Newsbusinesswire.com·20d ago·Neutral
SGRY Legal Notice: Surgery Partners Shareholders Are Notified to Contact BFA Law About the Ongoing Investigation Into the $23.50 Per Share Merger NEW YORK--(BUSINESS WIRE)---- $SGRY #BFA--Surgery Partners Shareholders are Notified to Contact BFA Law About the Ongoing Investigation into the $23.50 per Share Merger.
View source ↗ - Newsglobenewswire.com·23d ago·Neutral
SGRY Investigation Reminder: Surgery Partners' $23.50 per Share Merger Is Under Investigation – Contact BFA Law if You Hold Shares NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: SGRY) is being taken private by Bon Secours Mercy Health, Inc. Surgery Partners is incorporated in Delaware. If you are a current stockholder of Surgery Partners, Inc., …
View source ↗ - Newsbusinesswire.com·27d ago·Negative
SGRY Investors Have Opportunity to Join Surgery Partners, Inc. Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $SGRY--SGRY Investors Have Opportunity to Join Surgery Partners, Inc. Fraud Investigation with SBS Law.
View source ↗ - Newszacks.com·60d ago·Neutral
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock? Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
View source ↗ - Newsseekingalpha.com·104d ago·Positive
Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·104d ago·Positive
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates Surgery Partners (SGRY) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.17 per share a year ago.
View source ↗
Earnings
Mon, Mar 1(in 3 months)
Consensus estimate $0.12 per share
Typical surprise +6.3% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Nov 9$0.16 vs $0.11beat
- Mon, Aug 10$0.10 vs $0.06beat
- Tue, May 5$-0.03 vs $-0.15beat
- Mon, Mar 2$0.12 vs $0.31miss
- Mon, Nov 10$0.13 vs $0.19miss
- Tue, Aug 5$0.17 vs $0.16beat
Estimates and results for SGRY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by SGRY officers and directors.
- Bought
- $305k
- Sold
- $7.4m
2 trades
35 trades
- Deluca Teresabought
- Deluca Teresabought
- Doherty David Tsold
- Evans Jason Ericsold
- Burkhalter Daniellesold
- Brittenham Marissasold
- Baldock Jennifersold
- Evans Jason Ericsold
62 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in SGRY.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
